FDA panel backs Gilead’s Truvada to prevent HIV

WASHINGTON (Reuters) – A U.S. Food and Drug Administration panel of outside experts recommended Gilead Sciences Inc’s Truvada as a treatment for preventing HIV infection among people at risk for contracting AIDS, including homosexual and bisexual men. In a move that could lead to a new milestone for treatment in the evolution of the worldwide AIDS epidemic, the FDA advisory committee voted 19-3 to endorse the drug’s use for controlling HIV infection among the highest risk group – men who have sex with men. …

U.S. charges more than 100 over Medicare fraud schemes

WASHINGTON (Reuters) – Authorities have charged 107 people including doctors and nurses for trying to defraud the federal Medicare healthcare program for the elderly and disabled of about $452 million, the Obama administration said on Wednesday. At least 75 people in Miami, Houston and Baton Rouge were charged during the last two days for submitting false billing for home health care, mental health services, HIV infusions and physical therapy, among other charges. …

1 4 5 6 7 8 10